Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Medtronic complements bone healing portfolio with Osteotech acquisition

Aug. 18, 2010

LIPO-102 reduces abdominal fat in phase IIa study

Aug. 17, 2010

FDA approves ella tablets for emergency contraception

Aug. 17, 2010

FDA grants orphan status to becaplermin in osteochondritis dissecans

Aug. 13, 2010

Agile Therapeutics begins phase III trial of contraceptive patch AG-200-15

Aug. 13, 2010

Vyteris reports phase II data on transdermal patch for female infertility

Aug. 13, 2010

Cannabinoids show promise in models of inflammation and bone loss

Aug. 13, 2010

PregLem inlicenses bentamapimod from Merck Serono for postoperative adhesions and endometriosis

Aug. 13, 2010

Karo Bio to present phase III development plan for eprotirome in high-risk HeFH

Aug. 12, 2010

Acrux issues update on female health products

Aug. 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...